NEPHROGENEX INC Common Stock

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch NRXGQ and buy or sell other stocks, ETFs, and their options commission-free!

About NRXGQ

Medpace Research, Inc. is a pharmaceutical company, which focuses on the development of therapeutics to treat kidney disease, an area of significant unmet medical need. The company was founded by Billy G. 

CEO
John P. Hamill, CPA
CEOJohn P. Hamill, CPA
Employees
Employees
Headquarters
Cincinnati, Ohio
HeadquartersCincinnati, Ohio
Founded
2004
Founded2004
Employees
Employees

NRXGQ Key Statistics

Market cap
Market cap
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
5.69K
Average volume5.69K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.16
52 Week high$0.16
52 Week low
$0.002
52 Week low$0.002

Stock Snapshot

NEPHROGENEX INC Common Stock(NRXGQ) stock is priced at $0.00.

During the trading day, NEPHROGENEX INC Common Stock(NRXGQ) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading volume for NEPHROGENEX INC Common Stock(NRXGQ) stock has reached 0, versus its average volume of 5.69K.

The stock's 52-week range extends from a low of $0.00 to a high of $0.16.

The stock's 52-week range extends from a low of $0.00 to a high of $0.16.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.